Decline in NRF2-regulated Antioxidants in Chronic Obstructive Pulmonary Disease Lungs Due to Loss of Its Positive Regulator, DJ-1

• Published in: American journal of respiratory and critical care medicine Vol. 178; no. 6; pp. 592 - 604
• Main Authors: Malhotra, Deepti, Thimmulappa, Rajesh, Navas-Acien, Ana, Sandford, Andrew, Elliott, Mark, Singh, Anju, Chen, Linan, Zhuang, Xiaoxi, Hogg, James, Pare, Peter, Tuder, Rubin M, Biswal, Shyam
• Format: Journal Article
• Language: English
• Published: New York, NY Am Thoracic Soc 15.09.2008; American Lung Association; American Thoracic Society
• Subjects: Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy; Animals; Antioxidants; Antioxidants - analysis; B. Chronic Obstructive Pulmonary Disease; Biological and medical sciences; Cells, Cultured; Chronic obstructive pulmonary disease; Chronic obstructive pulmonary disease, asthma; Cigarettes; Epithelial Cells; Female; Fibroblasts; Glutathione - metabolism; Humans; Intensive care medicine; Intracellular Signaling Peptides and Proteins - physiology; Lipid Peroxidation; Lung - chemistry; Lung diseases; Lungs; Male; Medical sciences; Mice; Mice, Inbred Strains; Middle Aged; NAD(P)H Dehydrogenase (Quinone) - analysis; NF-E2-Related Factor 2 - analysis; NF-E2-Related Factor 2 - physiology; Oncogene Proteins - physiology; Oxidative stress; Oxidative Stress - drug effects; Oxidative Stress - physiology; Pathogenesis; Pneumology; Protein Deglycase DJ-1; Proteins; Pulmonary Disease, Chronic Obstructive - metabolism; Pulmonary Disease, Chronic Obstructive - physiopathology; Signal Transduction - physiology; Smoking; Smoking - metabolism; Smoking - physiopathology; Thiobarbituric Acid Reactive Substances - analysis; Transcription factors; Lung disease; Oxidative stress; Intensive care; NRF2; Respiratory disease; antioxidants; Bronchus disease; Chronic obstructive pulmonary disease; DJ-1; Antioxidant; Resuscitation
• ISSN: 1073-449X; 1535-4970
• DOI: 10.1164/rccm.200803-380OC

Oxidative stress is a key contributor in chronic obstructive pulmonary disease (COPD) pathogenesis caused by cigarette smoking. NRF2, a redox-sensitive transcription factor, dissociates from its inhibitor, KEAP1, to induce antioxidant expression that inhibits oxidative stress. To determine the link between severity of COPD, oxidative stress, and NRF2-dependent antioxidant levels in the peripheral lung tissue of patients with COPD. We assessed the expression of NRF2, NRF2-dependent antioxidants, regulators of NRF2 activity, and oxidative damage in non-COPD (smokers and former smokers) and smoker COPD lungs (mild and advanced). Cigarette smoke-exposed human lung epithelial cells (Beas2B) and mice were used to understand the mechanisms. When compared with non-COPD lungs, the COPD patient lungs showed (1) marked decline in NRF2-dependent antioxidants and glutathione levels, (2) increased oxidative stress markers, (3) significant decrease in NRF2 protein with no change in NRF2 mRNA levels, and (4) similar KEAP1 but significantly decreased DJ-1 levels (a protein that stabilizes NRF2 protein by impairing KEAP1-dependent proteasomal degradation of NRF2). Exposure of Bea2B cells to cigarette smoke caused oxidative modification and enhanced proteasomal degradation of DJ-1 protein. Disruption of DJ-1 in mouse lungs, mouse embryonic fibroblasts, and Beas2B cells lowered NRF2 protein stability and impaired antioxidant induction in response to cigarette smoke. Interestingly, targeting KEAP1 by siRNA or the small-molecule activator sulforaphane restored induction of NRF2-dependent antioxidants in DJ-1-disrupted cells in response to cigarette smoke. NRF2-dependent antioxidants and DJ-1 expression was negatively associated with severity of COPD. Therapy directed toward enhancing NRF2-regulated antioxidants may be a novel strategy for attenuating the effects of oxidative stress in the pathogenesis of COPD.